$19.88 -0.11 (%) Akorn Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Magic Recipe Movers - The Trump Effect

    TalkMarkets | Nov. 13, 2016 | 22:45PM EST
  2. Stocks Remain Indecisive; Jack In The Box, Fitbit Score Big Gains

    Investors Business Daily | Aug. 4, 2016 | 14:29PM EST
  3. Stock Futures Up, Europe Rallies On BOE Vote; Monster On Deck

    Investors Business Daily | Aug. 4, 2016 | 07:58AM EST
  4. John Paulson Bulks Up Health Care Bet

    GuruFocus | Feb. 17, 2016 | 17:02PM EST
  5. Top-Notch Funds Buying Constellation, Northrop Grumman

    IBD | Jan. 8, 2016 | 17:56PM EST
  6. Piper Jaffray: Akorn's Stock Will Be Delisted In 2016

    Benzinga | Dec. 18, 2015 | 11:18AM EST
  7. Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016

    Benzinga | Dec. 18, 2015 | 10:52AM EST
  8. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

    Benzinga | Oct. 27, 2015 | 03:23AM EST
  9. Biotechs, Medicals Whacked As Nasdaq Trades Near Day's Low

    IBD | Oct. 6, 2015 | 12:23PM EST
  10. Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon

    Benzinga | Sep. 17, 2015 | 06:00AM EST
  11. The Coming Drug-Patent Cliff Is Pushing This Portfolio Up

    Benzinga | Aug. 20, 2015 | 13:48PM EST
  12. Akorn's

    IBD | Aug. 4, 2015 | 17:41PM EST
  13. ETFs For The Next Pharma Takeover Candidates

    Benzinga | Jul. 28, 2015 | 12:08PM EST
  14. 5 Mid-Caps With Unsustainable Cash Burn Rates

    Benzinga | Jul. 27, 2015 | 08:23AM EST
  15. Pharma Pair Trade? Susquehanna Starts Lannet At Buy, Akorn At Neutral

    Benzinga | Jul. 21, 2015 | 10:31AM EST
  16. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest EPS Growth Forecast For Next 5 Years

    Benzinga | Jun. 19, 2015 | 03:43AM EST
  17. View, Use IBD's Key Stock Ratings In Light Of The Market

    IBD | Jun. 5, 2015 | 13:52PM EST
  18. Analyst Knocks High-Profile Biotech Merger Battle; Opportunities Elsewhere

    Benzinga | Jun. 3, 2015 | 16:05PM EST
  19. Health Care Mutual Funds Top In May: Close Look At Two Winners

    IBD | Jun. 2, 2015 | 17:43PM EST
  20. Who's The Next Big Pharma Acquisition?

    Benzinga | May. 29, 2015 | 10:20AM EST
  21. Celgene, Lannett Lead Boisterous Day For Drugmakers

    IBD | May. 18, 2015 | 14:56PM EST
  22. Analysts Disagree Over Significance of Akorn, Inc's Financial Errors

    GuruFocus | Apr. 28, 2015 | 16:17PM EST
  23. Nasdaq Leads Market Lower As Medical Stocks Tumble

    IBD | Apr. 27, 2015 | 15:16PM EST
  24. Stocks Fade; Apple Up Ahead Of Q2; Akorn Thrashed

    IBD | Apr. 27, 2015 | 10:46AM EST
  25. Akorn Downgraded, Stock Falls On 'Credibility Gap'

    IBD | Apr. 27, 2015 | 10:26AM EST
  26. Stocks Strong In Early Going; Autohome Breaks Out

    IBD | Apr. 27, 2015 | 09:43AM EST
  27. Morning Market Losers

    Benzinga | Apr. 27, 2015 | 08:53AM EST
  28. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 27, 2015 | 07:08AM EST
  29. After-Hours Movers Friday: Akorn Inc., Weight Watchers International Inc.

    Benzinga | Apr. 25, 2015 | 10:35AM EST
  30. Akron Will Restate Earnings; Drug Stock Tumbles

    IBD | Apr. 24, 2015 | 16:16PM EST
  31. Stocks Finish Solid Week; Akorn Restates 2014 Revenue

    IBD | Apr. 24, 2015 | 15:55PM EST
  32. Nasdaq Takes Lead In Mixed Open; Microsoft Surges, Biogen Dives

    IBD | Apr. 24, 2015 | 09:35AM EST
  33. Nasdaq Hits Record Close; Google, Amazon Rise After Hours

    IBD | Apr. 23, 2015 | 15:50PM EST
  34. Nasdaq Nears 2000 Bubble High As Volume Rises

    IBD | Apr. 23, 2015 | 13:58PM EST
  35. Akorn Leads Top Generic-Drug Stocks, Nears Buy Point

    IBD | Apr. 20, 2015 | 17:06PM EST
  36. 5 ETF Trends To Watch As Assets, Strategies Multiply

    IBD | Apr. 17, 2015 | 19:04PM EST
  37. 5 Top IBD 50 Stocks Stay On Course Despite Sell-Off

    IBD | Apr. 17, 2015 | 17:51PM EST
  38. IBD 50 Analysis: Akorn Evolves With Diverse Product Line

    IBD | Apr. 17, 2015 | 17:27PM EST
  39. Global Worries Sink U.S. Stocks; Apple Breaches Support Level

    IBD | Apr. 17, 2015 | 15:37PM EST
  40. Stock Futures Grapple Higher; Biogen, Akorn Lead IBD 50 List

    IBD | Apr. 15, 2015 | 08:04AM EST
  41. Alert: JP Morgan Just Started Akorn At Overweight

    Benzinga | Apr. 15, 2015 | 06:32AM EST
  42. Stock Market Takes A Break; Smith & Wesson Up After Close

    IBD | Mar. 3, 2015 | 16:59PM EST
  43. Stocks In Red Ahead Of Close; Alibaba At Post-IPO Low

    IBD | Mar. 3, 2015 | 15:14PM EST
  44. Stocks Off Lows In Afternoon; Akorn Dives 10%

    IBD | Mar. 3, 2015 | 13:23PM EST
  45. Monday's After-Hours Movers: Ocwen Financial, NutriSystem And McDermott International Lead The Pack

    Benzinga | Mar. 2, 2015 | 19:15PM EST
  46. AKORN PHARMA

    IBD | Mar. 2, 2015 | 18:45PM EST
  47. Akorn, Avago Lead IBD 50 Stocks In Earnings Growth

    IBD | Feb. 28, 2015 | 08:02AM EST
  48. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 27, 2015 | 16:27PM EST
  49. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 26, 2015 | 19:47PM EST
  50. Splunk Shoots Up After Hours; Monster Beverage Also Up

    IBD | Feb. 26, 2015 | 16:54PM EST
Trading Center